Hematopoietic/Lymphoid Cancer Terminated Phase 1 Trials for Alvocidib (DB03496)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070239Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic MalignanciesTreatment